{"name":"The Medicines Company","slug":"the-medicines-company","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"ALN-PCSSC","genericName":"ALN-PCSSC","slug":"aln-pcssc","indication":"Other","status":"phase_2"},{"name":"Placebo (D5W)","genericName":"Placebo (D5W)","slug":"placebo-d5w","indication":"Used as a placebo control in clinical trials","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Standard of Care IV antihypertensive","genericName":"Standard of Care IV antihypertensive","slug":"standard-of-care-iv-antihypertensive","indication":"Hypertension","status":"phase_3"},{"name":"Angiomax (bivalirudin)","genericName":"Angiomax (bivalirudin)","slug":"angiomax-bivalirudin","indication":"Anticoagulation during percutaneous coronary intervention (PCI)","status":"phase_3"}]}],"pipeline":[{"name":"ALN-PCSSC","genericName":"ALN-PCSSC","slug":"aln-pcssc","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Standard of Care IV antihypertensive","genericName":"Standard of Care IV antihypertensive","slug":"standard-of-care-iv-antihypertensive","phase":"phase_3","mechanism":"Blocks the action of angiotensin II at its receptor, leading to vasodilation and decreased blood pressure.","indications":["Hypertension"],"catalyst":""},{"name":"Angiomax (bivalirudin)","genericName":"Angiomax (bivalirudin)","slug":"angiomax-bivalirudin","phase":"phase_3","mechanism":"Bivalirudin is a direct thrombin inhibitor that binds to and blocks thrombin, preventing blood clot formation.","indications":["Anticoagulation during percutaneous coronary intervention (PCI)","Acute coronary syndrome (ACS) in patients undergoing PCI"],"catalyst":""},{"name":"Placebo (D5W)","genericName":"Placebo (D5W)","slug":"placebo-d5w","phase":"marketed","mechanism":"D5W (dextrose 5% in water) is an intravenous fluid that provides hydration and a modest amount of glucose for energy.","indications":["Used as a placebo control in clinical trials"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPZlFCRE0tR09IcFR6RXFhYmRTeTcyRTVrT3ByNHUzRXN4VFFBZExzMGtmNkNwa09NX0VFd3EzaUhSVmZpSTJkRFlqOFBuYVNpWHNBLWE3WjlkMjM2bWVhYS1zYTllbnRHb1JKV0l5ZlQzTEFaSmUzYW5pS2NiRkowZVZLU183Z0dsM2psTjZhVG5UNDdBTzM4?oc=5","date":"2026-02-14","type":"pipeline","source":"The Motley Fool","summary":"Best Pharmaceutical Stocks for 2026 and How to Invest in Them - The Motley Fool","headline":"Best Pharmaceutical Stocks for 2026 and How to Invest in Them","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOMHNxeFlMbmszZFNqc29NZmhWTGZjZDJrZ0JMX0haTkpiSjlhUUJSZWt1d0llRU9WX01rYmVGdW04MEJXX2tDNXVYdUNULVhSbjlUNzRNMkdya0FSOUVQY0hJZ3llYzV2U2tqeThVZGJWdXJGLWM1MEpibWZYZF9BeVNMYjRRX2tGSUo1UGh4SW4tQQ?oc=5","date":"2026-01-16","type":"deal","source":"NPR","summary":"Trump struck deals with 16 drug companies. But they're still raising prices this year - NPR","headline":"Trump struck deals with 16 drug companies. But they're still raising prices this year","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPVmFORC1Wc3dhay1sYm5pOFp2c2V3Vkt4RTJ5M0xYOC1acE1mWU9UZUZwS1VhcTFzanEteFBvX1pQdlNBZ3BlX1ZPZmpHNXNDekNxZTZHazNHTXo5ajdUTjd5d2ozeERLLW15VmNnb2NBaW1sUTN5bFZfVERtLUJ5ODBpczhJQQ?oc=5","date":"2026-01-15","type":"trial","source":"Endpoints News","summary":"Inside Fosun Pharma's ambition to be a global drug company - Endpoints News","headline":"Inside Fosun Pharma's ambition to be a global drug company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPT1JvdzBsbXlRSDRNU2tzSk1lckctQ1cxTTdlOUw3TjhTeklsWGRWbEdnR2cxeVd0c0hjUmhRLU1pMjJvVnlxcEhid0NiSzB1aDg4YkhtV1N3S05kcHdFbzlITjFhQWRGV296dVhtNzF3eGZpOVI4N2ZWTU5aT1J3REtXX2wxR3JjcjNfellYNHk2UllCamQ5QlBVTkVnMWpaeE5DUEJ3MUpZblZIS0E?oc=5","date":"2025-12-19","type":"pipeline","source":"pbs.org","summary":"WATCH: Trump announces 9 pharmaceutical companies will lower drug prices - pbs.org","headline":"WATCH: Trump announces 9 pharmaceutical companies will lower drug prices","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOVktjWFljYy1tZlAxZWp6VFc5aXMzeFFCQ1N3akU1cExHLVZLaTB4UEZ1Y3Ezb3E2OW5wa2lxMHE2akVKWHloaUF4el9iMFdpc2RibFhsX0Q3b19vTUp6dFRPV1VJTUVMc1FYTHRSOE1DYldsTlc0ZUhVTTU4Q3NBZ09pODlscVl2WGVIUnQtUUN6WnlqZWtPaGlrLXBORjE2S2fSAacBQVVfeXFMTmNJRkEtYmhxRHRMc0lXS2tnUkgwdlNiQkhUcXRzS05HWVdUUzBaakZXSExkTEJFNnZ0RVRrX0pfVkhlQ2lMQWVmaGI4R3cwZ3RIdEFFUG1WTms5bUttcVNmZTJFQ184cDZVUUNSXy1LNUZzcnRtWkI0Q25WQUFWTWQ5N0FXUnFFdVNKX3ZtVE0zY1Z6YjdBQXJPYi15OUlaSTJVbWFwczA?oc=5","date":"2025-12-19","type":"deal","source":"CNBC","summary":"Nine of the largest pharma companies ink deals with Trump to lower drug prices - CNBC","headline":"Nine of the largest pharma companies ink deals with Trump to lower drug prices","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFBaelNsVnItTm9Xd3B0Z1ltUU0wOHJIU0M4RWRhWm5aMFhRRUlVdjM3QmZqaDFTblotcmhNV3NUTGNFSG1YdU1hTmVheEpxRlE0RHFJdXhZX2paa2FWck1zRWxSdG5IbEVmOG93TU5MdFl3X0NmaHdTMDhHa0U?oc=5","date":"2025-11-19","type":"pipeline","source":"National Post","summary":"Is your doctor receiving payments from a drug company? There's no easy way to find out - National Post","headline":"Is your doctor receiving payments from a drug company? There's no easy way to find out","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPaEh4YlR4dlM0MFpfQ29UTmhXZkVxZ1B2RDA1UU4tYTgxZVQ1SlEtTy1EVi13M0RrR25OQTRHbGxPN2xvYm5qT19FUkVPVEkzaWtUZEFIUE40bTM3d19waFB6M20xbkRiUXdoX291X0x5eXpVdzVOd1lyblZoSkpFdEZ4enVLejduT3dBQ21FSVZNVWxDSVVMZFhMMEpKR2Jh?oc=5","date":"2025-11-06","type":"pipeline","source":"Pharmaceutical Commerce","summary":"Mark Cuban Cost Plus Drug Company Adds Starjemza to Prescription Drug Portfolio - Pharmaceutical Commerce","headline":"Mark Cuban Cost Plus Drug Company Adds Starjemza to Prescription Drug Portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPejR1Nncwa1B6UlBYRkhoM29BenVNTjluQmN3NHR6ZWZMcmdWdlZERDNaUC1XRFN6ZUdwNUlWdFRDTTdEdm5ZV2VwVmlmM3pUSHRvR3BHMGFybUM5ckxHbEhaR3ZYVWlwZ3R5RVVMV2d0VVhFRlR1N01kVUpvTm0tRDNOaHY2aFdCenlQUi1DZlF6bk9mRy1KRGlsUVprQQ?oc=5","date":"2025-05-15","type":"pipeline","source":"politico.eu","summary":"Big Pharma is using tariffs to hold Europe to ransom - politico.eu","headline":"Big Pharma is using tariffs to hold Europe to ransom","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxPZFNLcFBpYmg0aG8wQ05oT1IwNEZ4U3J0SHBIUVQwNExmSlBLdENvT2xKdklmTFotVjJDamZfNEVPZ0tqRG40QzN0VzM5eUFabkhsNWVXMTlkVWxnTGxmM2JncmhUbExzMzFLREcxV2YzX1lWR2dxc1BPaUVLMkZPeW9wMGZENmVEeXhOcVhDc01oeTNyakpMdUpwN3dBT09YbktjLVFWdmVjb3d6a3dtZVlxWGRVV1NWUEVsSm90Zy13aXd5SE1xcFQyMnlFU0tFbjFGdFVqZnJOVFZvUTBkR1NvczJuYWFUa0ZlRGZ1cUdpTWNBbUpmVl9RdXY3cTBZV3l1QXBVTHRXazJvQXZQT1JVbUxZUUhvd0JfYzlB?oc=5","date":"2020-01-06","type":"pipeline","source":"Novartis","summary":"Novartis successfully completes acquisition of The Medicines Company, adding a potentially first-in-class, investigational cholesterol-lowering therapy inclisiran - Novartis","headline":"Novartis successfully completes acquisition of The Medicines Company, adding a potentially first-in-class, investigation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPc1dpTmVPRkRJWW9OamJIY3dEQ0h1TzEwRjZHdDk5cXlVTmI0NjlHYjl3WDgya0FBSkhCY2MtbGYyNFdkOXlLTEY2eHhjQmhJSEJKSFN5TTROTXFKYXB2eEx4RmJSelQ4NnVxcXNBZzNheW5yRFZuWlVjSHFUd21vbGtNbVU5TUZMM01hVGlMME5pNVZTeW5iaTBkSS0tUjVyZFRKcGdhY0QxZWkzblZlS05JMUZzMVU?oc=5","date":"2019-12-10","type":"pipeline","source":"Fierce Pharma","summary":"Is $9.7B too big a price for The Medicines Company? Novartis itself seems to think so - Fierce Pharma","headline":"Is $9.7B too big a price for The Medicines Company? Novartis itself seems to think so","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQZVhnU3FuOE9McTBteFZkQ0FFeUtiQ1BXbkhBTW1QamhGeUFSY0NyRVFHeTRjdFdiRFNiVHlJbl9HaDhaM1oyUzJ5OGd6Q3lERWh0ZVFFUUpZTkx3VUplRVcxNGg4SDhzMTFvOU0tNTBPbXpoajdPenU5SWhTSjJzTl9nMUJkeU9nUGtXNjk0SQ?oc=5","date":"2019-11-25","type":"pipeline","source":"Fierce Biotech","summary":"Novartis strikes $9.7B takeover of The Medicines Company - Fierce Biotech","headline":"Novartis strikes $9.7B takeover of The Medicines Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPMjR1LUVEQWdleml1WEtINVFzSEhpYkRTazlOU3UtbDBUdGRXcFBzeWdPTEptTERkckxnSFJLQmI2UnNxaFVCVng5U2ZWNHpPQ1RCRDNaOTJURS1sTVlOU25kRzVhNTZYS3RPN1E2Y21mUDhvcGFkQlN3NEx6eHBLZlIxVzlrSFM4c1RsT3Rqdy04YmdqdE9QQUdUYUlURnZv?oc=5","date":"2019-03-11","type":"pipeline","source":"Forbes","summary":"The Medicines Company: Innovating Innovation - Forbes","headline":"The Medicines Company: Innovating Innovation","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_2":1,"phase_3":2,"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}